Aiming to tackle the high risk of heart problems among older Americans with obesity, Medicare is contemplating an expansion of coverage for a weight-loss medication known as semaglutide.
Cardiovascular clinical trials have been shown to lack female leadership – yet female-led trials have an increase in female participants, making the trials yield more meaningful results.
Good, social relationships mean an individual receives but also gives significant support - now, scientists suggest that the giving part may improve future health.
Data reveals that patients with heart disease who come from disadvantaged communities experience more complications after their surgery – including a higher risk of death.
Though the UK’s recommended alcohol limit is under 14 units weekly, researchers still suggest less, as the risk of cardiovascular diseases can still be increased by even moderate amounts.
Teaching children about healthy habits can achieve lasting lifestyle changes, lowering cardiovascular disease risk through a multidisciplinary approach.
According to a new study, nearly one in five patients with heart disease use mental health drugs, leading to almost a doubled risk of premature deaths with the condition.
Wearable devices are being used as part of a cardiology programme “Our Hearts Our Minds” to support patients at risk of, or who have a cardiovascular condition.
Claire Kendal-Wright, PhD, from Chaminade University of Honolulu, argues that when it comes to understanding the normal human parturition mechanisms, danger associated molecular patterns may be part of the answer.
A US study found higher blood pressure levels were associated with the COVID-19 pandemic, due to stay-at-home orders impacting healthy lifestyle behaviours.
Latest study shows people may be able to reduce their risk of atrial fibrillation by avoiding certain triggers like alcohol, in consideration of other lifestyle factors.
A new study, demonstrating how circadian rhythms in heart cells alter daily heart function, may explain why shift workers are vulnerable to heart complications.
Dr Campbell Rogers, Chief Medical Officer at HeartFlow, examines how the healthcare industry can best prepare to combat heart disease in a post-pandemic environment.
